Interlaboratory comparison of the assessment of P450 activities in human hepatic microsomal samples
- 1 January 1998
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 28 (5) , 493-506
- https://doi.org/10.1080/004982598239416
Abstract
1. Although the importance of in vitro technology in supporting drug development is widely accepted, there is no real consensus about which approaches should be taken, which substrates should be used, or on the reliability and application of in vitro data. Consequently, as part of a collaborative project to characterize human liver with respect to the major forms of cytochrome P450, an interlaboratory comparison of the analysis of samples for form-specific activities was undertaken. 2. Microsomal fractions were isolated from five different human liver samples taken from the liver bank maintained at the Royal Postgraduate Medical School (RPMS). Aliquots from the five samples were sent to the 11 collaborating laboratories for characterization using their in-house, form-specific assays for cytochrome P450 activities. Although each laboratory assayed protein concentration, total cytochrome P450 content and enzyme activities were calculated using the protein estimation generated by RPMS to eliminate this possible source of variability. 3. With the exception of one laboratory, all estimates of protein concentration were similar (coefficient of variation, CoV, 9-13%) and the rank-order of the five samples was consistent across the laboratories. There was greater variability in the estimates of total cytochrome P450 content (CoV 28-43%), although again rank order of the samples across laboratories was fairly consistent. 4. The various laboratories used a number of different probe substrates, together with a range of conditions (substrate concentration, time of incubation, amount of protein), to assay for activity of CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4. However, apart from the occasional outlier, the five samples were ranked for activity of all these forms of cytochrome P450 with a high degree of consistency by the various laboratories and the choice of substrate had no appreciable effect on the ranking of the samples. 5. While this interlaboratory comparison has shown that greater consistency in the approach to in vivo determinationof drug-metabolizing activity is desirable,therewas little indication that any particular approach or substrate was superior to the others.Keywords
This publication has 25 references indexed in Scilit:
- Human P450 metabolism of warfarinPharmacology & Therapeutics, 1997
- The importance of substrate concentration in determining cytochromes P450 therapeutically relevant in vivoPharmacogenetics, 1994
- Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamilyBiochemical Pharmacology, 1994
- Saccharomyces cerevisiae: An alternative source for human microsomal liver enzymes and its use in drug interaction studiesToxicology, 1993
- Catalytic activities of human debrisoquine 4-hydroxylase cytochrome P450 (CYP2D6) expressed in yeastBiochemical Pharmacology, 1992
- Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobioticsBiochemical Journal, 1992
- Oxidation of dihydropyridine calcium channel blockers and analogs by human liver cytochrome P-450 IIIA4Journal of Medicinal Chemistry, 1991
- PhenacetinO-deethylation by human liver microsomes: Kinetics and propranolol inhibitionXenobiotica, 1988
- Biotransformation of caffeine by microsomes from human liverBiochemical Pharmacology, 1987
- Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens.Published by Wiley ,1980